Advertisement
Singapore markets close in 3 hours 14 minutes

  • Straits Times Index

    3,279.54
    -13.59 (-0.41%)
     

  • Nikkei

    37,640.77
    -819.31 (-2.13%)
     

  • Hang Seng

    17,278.04
    +76.77 (+0.45%)
     

  • FTSE 100

    8,040.38
    -4.43 (-0.06%)
     

  • Bitcoin USD

    64,292.01
    -2,445.09 (-3.66%)
     

  • CMC Crypto 200

    1,386.42
    -37.68 (-2.65%)
     

  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     

  • Dow

    38,460.92
    -42.77 (-0.11%)
     

  • Nasdaq

    15,712.75
    +16.11 (+0.10%)
     

  • Gold

    2,329.80
    -8.60 (-0.37%)
     

  • Crude Oil

    82.96
    +0.15 (+0.18%)
     

  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     

  • FTSE Bursa Malaysia

    1,570.29
    -1.19 (-0.08%)
     

  • Jakarta Composite Index

    7,157.23
    -17.30 (-0.24%)
     

  • PSE Index

    6,581.84
    +9.09 (+0.14%)
     

Here's Why Wave Life Sciences Crashed Today

Brian Orelli, PhD, The Motley Fool
·2-min read
Here's Why Wave Life Sciences Crashed Today

Shares of Wave Life Sciences (NASDAQ: WVE) are down 29% at 1:29 p.m. EDT after the company announced that WVE-120102 and WVE-120101, two of its drugs to treat Huntington's disease, failed to show an effect in early stage clinical trials. Huntington's disease is caused by different mutations in the huntingtin protein. WVE-120101 and WVE-120102 are designed to reduce the expression of mutant huntingtin protein (mHTT) for patients with the SNP1 and SNP2 mutations, respectively.

Continue reading